SEC Form 6-K Summary
Business Context and Reporting Period
Medirom Healthcare Technologies Inc., a Japanese foreign private issuer, furnished this Form 6-K for April 2022. The filing, dated April 22, 2022, reports the Company’s regaining compliance with Nasdaq continued listing standards.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial results.
Material Change
On April 19, 2022, Nasdaq notified the Company that the previously disclosed deficiency concerning the market value of its listed securities had been cured. Nasdaq closed the matter, and the Company was deemed compliant with the applicable continued listing standards of The Nasdaq Capital Market.
Outlook, Risks, and Unusual Items
The Company issued a press release on April 22, 2022 announcing its regained Nasdaq compliance. The filing provides no operating guidance, financial outlook, material contingencies, or additional risk discussion.
Investor Verification Items
- Review Exhibit 99.1 for the Company’s detailed announcement and any conditions associated with continued Nasdaq compliance.
- Verify whether subsequent filings disclose any additional listing deficiencies or market-value requirements.
- Consult the Company’s annual report and later filings for current financial performance, liquidity, debt, and operating outlook.